2Townsend DW,Beyer T,Kinahan PE,et al.Fusion imaging for whole body oncology with a combined PET and CT scanner.J Nucl Med,1999,40:148.
3David W.PET/CT:Today and tomorrow.J Nucl Med,2004,45:4s-5s.
4Freudenberg LS,Antoch G,Beger A,et al.Combined PET/CT Imaging:First clinical experimence at University of Essen.Hospital Radiology,2003,3:4-8.
5Pauwels EK,Ribeiro MJ,Stoot JH,et al.FDG accumulation and tumor biology.Nucl Med Biol,1998,25:317-322.
6Minn H,Leskinen-Kallio S,Lindholm P,et al.[18F] fluorodeoxyglucose uptake in tumors:kinetic vs.steady-stade methods with reference to plasma insulin.Comput Assist Tomogr,1993,17:115-123.
7Lonneux M,Lawson G,Ide C,et al.Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.Laryngoscope,2000,110:1493-1497.
8Fischbein NJ,AAssar OS,Caputo GR,et al.Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.AJNR Am J Neuroradiol,1998,19:1189-1196.
9Unger JM,Flaherty LE,Liu PY,et al.Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncclogy Group trials.Cancer,2001,91:1148-1155.
10Hudgins PA,Burson JG,Gussack GS,et al.CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction.AJNR Am J Neuroradiol,1994,15:1689-1694.
